π About
- Ewing sarcoma is a rare, aggressive primary bone tumour, usually affecting children <15 years old.
- It is the second most common malignant bone tumour in children after osteosarcoma.
𧬠Aetiology
- Typical age: 5β15 years (younger than osteosarcoma).
- Arises from primitive neuroectodermal cells (neural crest origin).
- π Classic cytogenetic feature: t(11;22)(q24;q12) translocation β EWSR1βFLI1 fusion gene.
π©Ί Clinical Features
- π Most common sites: long bones (femur, pelvis, tibia), ribs, and flat bones.
- π©Έ Localised pain and swelling (often mistaken for trauma).
- π§± Palpable mass or restricted movement near affected joint.
- π‘οΈ Systemic βB symptomsβ: fever, night sweats, weight loss.
- π Can mimic osteomyelitis β pain, fever, β inflammatory markers.
π Investigations
- Blood tests: FBC, U&E, ESR/CRP, ALP, LDH (β LDH = poor prognosis).
- X-ray: Classic βonion skinβ periosteal reaction π§
(layered new bone).
- MRI: Defines local tumour extent; differentiates from infection.
- Histology: Sheets of small round blue cells π¬.
- Genetics: EWSR1βFLI1 fusion gene (t[11;22]) confirms diagnosis.
- Metastasis screening: CT chest, bone scan, PET for lung/bone mets.
π Management
- Chemotherapy: π Induction chemo (often vincristine, doxorubicin, cyclophosphamide, ifosfamide, etoposide).
- Local control:
- π¦ Radiotherapy β Ewing is radiosensitive (unlike osteosarcoma).
- βοΈ Surgery β resection or limb-salvage where feasible.
- Combined modality therapy (chemo + surgery/radiotherapy) gives best outcomes.
π Prognosis
- Overall 5-year survival for localised disease β 60β70% π.
- With metastases at presentation: <30% β.
- Poorer outcomes with pelvic/axial disease, large tumour volume, or high LDH.
π§βπ« Exam Tip
Ewing sarcoma vs osteosarcoma:
- π§
Onion skin X-ray (Ewing) vs π Sunburst pattern (Osteosarcoma).
- π Ewing is radiosensitive, Osteosarcoma is radio-resistant.
- π Ewing often involves diaphysis; Osteosarcoma prefers metaphysis.
Cases β Ewing Sarcoma
- Case 1 β Teenager with bone pain π¦΄: A 14-year-old boy presents with progressive pain and swelling in his right femur. Exam: tender, warm swelling over the diaphysis. X-ray: permeative βmoth-eatenβ lesion with onion-skin periosteal reaction. MRI: soft tissue extension. Diagnosis: Ewing sarcoma of femoral shaft. Managed with neoadjuvant chemotherapy followed by surgery and radiotherapy.
- Case 2 β Pelvic tumour π¨: A 12-year-old girl presents with pelvic pain, limp, and urinary frequency. Exam: large pelvic mass. Imaging: destructive iliac lesion with periosteal reaction; biopsy confirms small round blue cell tumour with EWSR1 gene translocation. Diagnosis: Ewing sarcoma of pelvis. Managed with chemotherapy, surgery if resectable, and radiotherapy.
- Case 3 β Metastatic presentation π¬οΈ: A 16-year-old boy presents with rib pain, weight loss, and cough. Exam: tender chest wall swelling. CT: destructive rib lesion with large soft tissue mass and lung metastases. Diagnosis: Ewing sarcoma of rib with pulmonary metastases. Managed with systemic chemotherapy, local radiotherapy, and palliative surgical options as appropriate.
Teaching Point π©Ί: Ewing sarcoma is a highly malignant small round blue cell tumour, second most common bone cancer in children/adolescents.
Typical sites: pelvis, femur, tibia, ribs.
X-ray: permeative lytic lesion, onion-skin periosteal reaction.
Histology/genetics: EWSR1-FLI1 translocation.
Management: multi-agent chemotherapy + local control with surgery/radiotherapy. Prognosis worse if metastases present.